Loading…
Impact BioMedical Inc. is projected to decline to $0.4467 by 2027, a -9% move from its current price of $0.4906. IBO is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $0.4686 | $0.4904 | $0.5131 | -0.05% |
| May 30 | $0.4596 | $0.4901 | $0.5226 | -0.10% |
| May 31 | $0.4528 | $0.4899 | $0.5299 | -0.15% |
| Jun 1 | $0.4471 | $0.4896 | $0.5362 | -0.20% |
| Jun 2 | $0.4421 | $0.4894 | $0.5417 | -0.25% |
| Jun 3 | $0.4376 | $0.4891 | $0.5467 | -0.30% |
| Jun 4 | $0.4335 | $0.4889 | $0.5513 | -0.35% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.4335 | $0.4889 | $0.5513 | -0.35% |
| Week 2 | $0.4111 | $0.4872 | $0.5774 | -0.70% |
| Week 3 | $0.3943 | $0.4855 | $0.5977 | -1.05% |
| Week 4 | $0.3804 | $0.4838 | $0.6151 | -1.39% |
| Week 5 | $0.3685 | $0.4821 | $0.6306 | -1.74% |
| Week 6 | $0.3579 | $0.4804 | $0.6447 | -2.08% |
| Week 7 | $0.3484 | $0.4787 | $0.6578 | -2.43% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Impact BioMedical Inc. is a healthcare company that discovers, develops, and commercializes products and technologies to address unmet needs in human healthcare and wellness for specialty biopharmaceuticals, antivirals, antimicrobials, consumer healthcare, and wellness products in the United States. The company operates Linebacker, a platform of small molecule electrophilically enhanced polyphenol compounds with application in oncology, inflammatory disorders, and neurology; and Laetose technology that is derived from a unique combination of sugar and inositol, which can inhibit the inflammatory and metabolic response of sugar alone.
It also develops functional fragrance formulation, a suite of functional fragrances containing specialized botanical ingredients with application as an antimicrobial, and as an additive in insect repellents, detergents, lotions, shampoo, fabrics, and other substances. In addition, the company develops Equivir/Equivir G technology, a novel blend of polyphenols, which have demonstrated antiviral effects for use as health supplements and medications. Further, it is developing 3F (functional fragrance formulation), a formulation of botanical ingredients.
Impact BioMedical Inc. was incorporated in 2018 and is based in Houston, Texas. Impact BioMedical Inc. operates as a subsidiary of DSS BioHealth Security, Inc.
Impact BioMedical Inc. (IBO) is a healthcare company with a current price of $0.4906 and a market capitalization of $52.9M, ranking 4513. The stock trades in a near-term context that is described as NEUTRAL by technicals. The annualized volatility sits at 90%, reflecting a high-risk price path alongside potential upside.
A major floor 28.0% below — a decisive break under it would weaken the trend.
Price is testing support right now (0.1% away) — a key level to hold.
The nearest ceiling, 42.3% above — a clean break opens room to run.
A major ceiling 59.0% above — clearing it would confirm fresh momentum.
Key IBO support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of IBO market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $0.5234 | Sell | $0.519 | Sell |
| MA 10 | $0.5363 | Sell | $0.5409 | Sell |
| MA 20 | $0.589 | Sell | $0.5717 | Sell |
| MA 50 | $0.6145 | Sell | $0.5866 | Sell |
| MA 100 | $0.5491 | Sell | $0.5755 | Sell |
| MA 200 | $0.5555 | Sell | $0.6467 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 27.27 | Buy |
| Stoch RSI (14) | 0.00 | Buy |
| CCI (20) | -124.03 | Sell |
| Williams %R (14) | -100.00 | Info |
| MACD (12,26,9) | -0.01 | Sell |
| ROC (12) | -21.94 | Sell |
| Bollinger %B (20,2) | 0.07 | Neutral |
| Stochastic %K (14) | 0.00 | Buy |
| TRIX (15) | -0.52 | Sell |
| Awesome (5,34) | -0.10 | Sell |
| Ultimate (7,14,28) | 15.86 | Buy |
| Momentum (10) | -0.13 | Sell |
| Aroon Osc (25) | -100.00 | Sell |
| Hull MA (9) | 0.51 | Sell |
| ADX (14) | 22.98 | Sell |
| ATR (14) | 0.02 | Info |
Technical sentiment is NEUTRAL, with RSI14 at 30. The 50-day simple moving average is $0.6145 and the 200-day simple moving average is $0.5555. Support is reported at $0.491 and resistance at $0.698. The 30-day price range spans from $0.3637 to $0.6618.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.401 | $0.4906 | $0.7059 | 0% | Neutral | |
| $0.3315 | $0.4467 | $0.6487 | -9% | Neutral | |
| $0.397 | $0.5617 | $0.861 | +14% | Neutral | |
| $0.4764 | $0.7026 | $1.12 | +43% | Bullish | |
| $0.4191 | $0.6419 | $1.06 | +31% | Bullish | |
| $0.3806 | $0.6036 | $1.03 | +23% | Bullish | |
| $0.3486 | $0.5715 | $1.00 | +16% | Neutral | |
| $0.3474 | $0.5879 | $1.06 | +20% | Neutral | |
| $0.4188 | $0.7306 | $1.34 | +49% | Bullish | |
| $0.4445 | $0.7989 | $1.50 | +63% | Bullish | |
| $0.4367 | $0.9036 | $1.85 | +84% | Bullish | |
| $0.6708 | $1.49 | $3.43 | +204% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $0.401 | $0.4906 | $0.5823 | +0.00% |
| June 2026 | $0.4057 | $0.4835 | $0.5948 | -1.46% |
| July 2026 | $0.3878 | $0.4687 | $0.5893 | -3.06% |
| August 2026 | $0.4085 | $0.4992 | $0.6382 | +6.52% |
| September 2026 | $0.428 | $0.528 | $0.6841 | +5.76% |
| October 2026 | $0.4127 | $0.5136 | $0.6736 | -2.73% |
| November 2026 | $0.4046 | $0.5073 | $0.6723 | -1.23% |
| December 2026 | $0.4176 | $0.5273 | $0.7059 | +3.96% |
Click any year to see its month-by-month IBO forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Impact BioMedical Inc.'s 2026 outlook centres on $0.4906, within a $0.401 to $0.7059 range. That marks a 0% change versus current levels. A consolidation phase looks the most probable path here.
By 2027, IBO could reach as high as $0.6487, with a base case around $0.4467 and support toward $0.3315 — roughly -9% from $0.4906. Price action looks broadly range-bound.
Expect IBO to range from $0.397 to $0.861 through 2028. The $0.5617 average target implies a +14% move from current prices. That is up +26% on the projected 2027 average. A consolidation phase looks the most probable path here.
The IBO price prediction for 2029 points to an average of $0.7026 (low $0.4764, high $1.12) — a potential gain of +43% on today's $0.4906. Momentum favours further upside here.
In 2030, IBO is projected to trade between $0.4191 and $1.06, averaging $0.6419 — a potential gain of +31% from today's $0.4906. That is -9% versus the projected 2029 average. Buyers look set to stay in control over this stretch.
Impact BioMedical Inc.'s 2031 outlook centres on $0.6036, within a $0.3806 to $1.03 range. That is -6% versus the projected 2030 average. That marks a +23% change versus current levels. Momentum favours further upside here.
By 2032, IBO could reach as high as $1.00, with a base case around $0.5715 and support toward $0.3486 — roughly +16% from $0.4906. A consolidation phase looks the most probable path here.
Expect IBO to range from $0.3474 to $1.06 through 2033. The $0.5879 average target implies a +20% move from current prices. That is up +3% on the projected 2032 average. Price action looks broadly range-bound.
The IBO price prediction for 2034 points to an average of $0.7306 (low $0.4188, high $1.34) — a potential gain of +49% on today's $0.4906. Buyers look set to stay in control over this stretch.
In 2035, IBO is projected to trade between $0.4445 and $1.50, averaging $0.7989 — a potential gain of +63% from today's $0.4906. That is up +9% on the projected 2034 average. Momentum favours further upside here.
Impact BioMedical Inc.'s 2040 outlook centres on $0.9036, within a $0.4367 to $1.85 range. That is up +13% on the projected 2035 average. That marks a +84% change versus current levels. Buyers look set to stay in control over this stretch.
By 2050, IBO could reach as high as $3.43, with a base case around $1.49 and support toward $0.6708 — roughly +204% from $0.4906. Momentum favours further upside here.
Investing $1,000 in IBO today (≈ 2,038.320424 IBO) could be worth
$3,038.51
+$2,038.51 (+204%) by 2050 · US Dollar
Based on the average projected IBO price of $1.49 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in IBOwould be worth at today's price.
$1,000 invested in IBO on May 27, 2025 (≈ 1,872.659248 IBO) would be worth
$918.73
-$81.27 (-8.1%) today · 0.92× · US Dollar
Based on a IBO entry price of $0.534 vs. today's $0.4906.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $0.538 | $911.9 | -8.8% |
| 1 month ago | $0.66 | $743.33 | -25.7% |
| 3 months ago | $0.435 | $1,127.82 | +12.8% |
| 6 months ago | $0.446 | $1,100 | +10.0% |
| 1 year ago | $0.534 | $918.73 | -8.1% |
| All time (1.7y) ago | $2.68 | $183.06 | -81.7% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our IBO forecast.
Our base-case forecast reaches $0.98 around 2050.
Implied market cap at $0.98: $105.66M
The multi-year forecast shows a path of variable returns with bullish momentum in the later years. For 2026 the average price is $0.4906 and the 2026 forecast indicates a neutral stance with an average near the current price. In 2027 the average is $0.4467 (min $0.3315, max $0.6487) with a negative ROI of -9.
The forecast turns more constructive from 2028 onward, with 2028 average $0.5617 (max $0.861) and ROI 14.5, and 2029 average $0.7026 (max $1.12) with ROI 43.2 and a BULLISH sentiment. By 2030 the average is $0.6419 (min $0.4191, max $1.06) with ROI 30.8 and a BULLISH sentiment, followed by continued gains through 2031-2035. The 2031-2035 figures show gradual upside with 2031 avg $0.6036 (ROI 23), 2032 avg $0.5715 (ROI 16.5), 2033 avg $0.5879 (ROI 19.8), 2034 avg $0.7306 (ROI 48.9), and 2035 avg $0.7989 (ROI 62.9).
The forecast projects stronger upside in 2040 with average $0.9036 and max $1.85 (ROI 84.2), and remains bullish into 2050 with average $1.49 and max $3.43 (ROI 203.8). Overall, the long-run trajectory is characterized as BULLISH, albeit with notable risk and volatility.
Tap a question to reveal the answer.
The 2030 forecast shows an avg price of $0.6419 with a min of $0.4191 and a max of $1.06, and a ROI of 30.8%. The sentiment is BULLISH.
Near-term forecasts show 2026 avg $0.4906 with ROI 0 and NEUTRAL sentiment, followed by 2027 with ROI -9. The outlook improves in 2028 (ROI 14.5) and 2029 (ROI 43.2) with a BULLISH stance.
Yes, the maximum forecast across the horizon is $3.43 in 2050, which is above $2. This indicates the potential for prices to exceed $2 sometime before 2050 according to the forecast.
The 30-day picture shows NEUTRAL sentiment, RSI14 at 30, SMA50 of $0.6145, SMA200 of $0.5555, with support at $0.491 and resistance at $0.698. The 30-day range is $0.3637 to $0.6618.
For 2040, the avg price is $0.9036 with max $1.85 and ROI 84.2, sentiment BULLISH. For 2050, the avg price is $1.49 with max $3.43 and ROI 203.8, sentiment BULLISH.
Impact BioMedical Inc. Community Discussion
0Share your Impact BioMedical Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.